- Home
- SLXN vs SNTG Comparison
SLXN vs SNTG Comparison
Compare SLXN & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- SNTG
- Stock Information
- Founded
- SLXN 2008
- SNTG 2009
- Country
- SLXN Israel
- SNTG China
- Employees
- SLXN N/A
- SNTG N/A
- Industry
- SLXN
- SNTG Finance: Consumer Services
- Sector
- SLXN
- SNTG Finance
- Exchange
- SLXN NYSE
- SNTG Nasdaq
- Market Cap
- SLXN 5.2M
- SNTG 5.4M
- IPO Year
- SLXN N/A
- SNTG 2021
- Fundamental
- Price
- SLXN $2.44
- SNTG $1.97
- Analyst Decision
- SLXN Strong Buy
- SNTG
- Analyst Count
- SLXN 1
- SNTG 0
- Target Price
- SLXN $1.00
- SNTG N/A
- AVG Volume (30 Days)
- SLXN 1.3M
- SNTG 9.0K
- Earning Date
- SLXN 11-14-2024
- SNTG 12-24-2024
- Dividend Yield
- SLXN N/A
- SNTG N/A
- EPS Growth
- SLXN N/A
- SNTG N/A
- EPS
- SLXN N/A
- SNTG N/A
- Revenue
- SLXN N/A
- SNTG $146,472.00
- Revenue This Year
- SLXN N/A
- SNTG N/A
- Revenue Next Year
- SLXN N/A
- SNTG N/A
- P/E Ratio
- SLXN N/A
- SNTG N/A
- Revenue Growth
- SLXN N/A
- SNTG N/A
- 52 Week Low
- SLXN $0.21
- SNTG $1.52
- 52 Week High
- SLXN $13.56
- SNTG $8.45
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- SNTG 49.95
- Support Level
- SLXN N/A
- SNTG $1.85
- Resistance Level
- SLXN N/A
- SNTG $1.98
- Average True Range (ATR)
- SLXN 0.00
- SNTG 0.10
- MACD
- SLXN 0.00
- SNTG 0.00
- Stochastic Oscillator
- SLXN 0.00
- SNTG 35.11
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.